Resources / Private label

Private-Label Pen Injector Packaging and Branding Guide

Private-label work should make ownership and instructions clearer without blurring the difference between appearance changes and functional device changes.

Evidence approachLabelling and traceability statements follow FDA labelling references and ISO quality-system records. Brand-layer design is treated as commercial, not regulated, content.

Define the branding layer

List the requested device-body colors, logo location, printed scale artwork, labels, carton, insert and shipping packaging. Confirm which party supplies approved artwork and which party performs final regulatory review.

Logo and color references
Device marking area and method
Label owner and controlled copy
Carton dimensions and pack quantity
Language and market requirements
Artwork approval and revision history

Protect functional information

Dose windows, scale markings, warnings and user instructions should remain legible. A new graphic treatment must not imply an unsupported dose, application or approval.

Plan change control

Keep approved artwork files, physical color references and packaging specifications under revision control. Reorders should identify the approved revision rather than relying on screenshots or informal messages.

A brand layer can be changed quickly. Regulated label content cannot. Keep the two in separate files and separate approval routes.

Sources reviewed

Primary regulatory and standards records used for this procurement topic

FDAGeneral device labeling requirementsOpen primary record →FDAQuality system regulation labeling requirementsOpen primary record →

Decision table

Review area	Buyer action
Artwork	Separate brand artwork from regulated label content in your file structure.
Labeling	Confirm who appears as the legal manufacturer on the printed label.
Instructions	Check the instructions match the exact pen variant being shipped.
Traceability	Keep lot and expiry legible after the brand layer is applied.